# The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder

> **NCT04052451** · PHASE1 · COMPLETED · sponsor: **NuBiyota** · enrollment: 21 (actual)

## Conditions studied

- Depression, Anxiety

## Interventions

- **BIOLOGICAL:** MET-2

## Key facts

- **NCT ID:** NCT04052451
- **Lead sponsor:** NuBiyota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-16
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04052451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04052451, "The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04052451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*